/

Immunologie et infection

/

Screening of β2 Integrin Activation Inhibitors in Human Neutrophils

/

Neutrophils Screening Assay Using Flow Cytometry

Journal JoVE
Immunologie et infection

Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.

Journal JoVE Immunologie et infection

Neutrophils Screening Assay Using Flow Cytometry

Neutrophils Screening Assay Using Flow Cytometry

Screening of β2 Integrin Activation Inhibitors in Human Neutrophils

DOI:

10.3791/200756-v

•

01:03 min

•

February 02, 2024

•

Ziming Cao, Matthew J. Garcia, Larry A. Sklar^3,4,5, Angela Wandinger-Ness⁴, Zhichao Fan

¹Department of Immunology, School of Medicine,UConn Health, ²Center for Molecular Discovery,University of New Mexico Health Sciences Center, ³Comprehensive Cancer Center,University of New Mexico Health Sciences Center, ⁴Department of Pathology,University of New Mexico Health Sciences Center, ⁵Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico

Tags

Flow Cytometry Neutrophil Screening Assay 384 Well Plate Compound Treatment Fluorescence High-throughput Sample Agitation Mean Fluorescence Density Beta-2 Integrin Antagonists

Embed

AJOUTER À LA PLAYLIST

Usage Statistics

Vidéos Connexes

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

High-Throughput Screening of Compounds Using Neutrophils Isolated from Human Blood in a 384-Well Plate Format

Neutrophils Screening Assay Using Flow Cytometry

Read Article